Xvivo Perfusion AB (publ) (XVIPF)
OTCMKTS
· Delayed Price · Currency is USD
30.10
0.00 (0.00%)
Jul 4, 2025, 4:00 PM EDT
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of $963.53 million as of July 3, 2025. Its market cap has decreased by -25.45% in one year.
Market Cap
963.53M
Enterprise Value
933.55M
Revenue
85.18M
Ranking
n/a
PE Ratio
70.60
Stock Price
$30.10
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 56.07M to 963.53M, an increase of 1,618.42%. That is a compound annual growth rate of 25.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 639.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 557.29M |
| American Oncology Network | 418.01M |
| Northwest Biotherapeutics | 366.72M |